Cargando…

A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential

Malignant mesothelioma (MM) is an aggressive serosal tumor associated with asbestos exposure. We previously demonstrated that mesothelial cells differentiate into cells of different mesenchymal lineages and hypothesize that osseous tissue observed in a subset of MM patients is due to local different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lansley, S. M., Pedersen, B., Robinson, C., Searles, R. G., Sterrett, G., van Bruggen, I., Lake, R. A., Mutsaers, S. E., Prêle, C. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122867/ https://www.ncbi.nlm.nih.gov/pubmed/27886205 http://dx.doi.org/10.1038/srep36349

Ejemplares similares

Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
por: Birnie, Kimberly A., et al.
Publicado: (2017)

Mesothelial cell differentiation into osteoblast- and adipocyte-like cells
por: Lansley, Sally M, et al.
Publicado: (2011)

MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
por: Birnie, Kimberly A., et al.
Publicado: (2019)

Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma
por: Lim, Chuan Bian, et al.
Publicado: (2013)

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008)

Mesothelial cells in tissue repair and fibrosis
por: Mutsaers, Steven E., et al.
Publicado: (2015)

Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis
por: Lim, Chuan Bian, et al.
Publicado: (2015)

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
por: Meniawy, T M, et al.
Publicado: (2013)

Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models
por: Lam, Sze-Kwan, et al.
Publicado: (2022)

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
por: Creaney, J, et al.
Publicado: (2001)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015)

Malignant mesothelioma in construction workers: the Apulia regional mesothelioma register, Southern Italy
por: Vimercati, L., et al.
Publicado: (2019)

Response to comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'
por: Meniawy, T M, et al.
Publicado: (2014)

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma
por: Orozco Morales, M. Lizeth, et al.
Publicado: (2023)

Identification of tumor antigens in malignant mesothelioma
por: Kim, Ye-Rin, et al.
Publicado: (2017)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

A subset of microRNAs defining the side population of a human malignant mesothelioma cell line
por: Kim, Myung-Chul, et al.
Publicado: (2017)

Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural Mesothelioma
por: Torricelli, Federica, et al.
Publicado: (2020)

Preclinical Models of Malignant Mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2020)

Malignant mesothelioma: Canadian perspective and research directions
por: Lee, C.W., et al.
Publicado: (2008)

Malignant Mesothelioma and Delivery of Polyphenols
por: Bishop, Karen S., et al.
Publicado: (2016)

Genomics and Epigenetics of Malignant Mesothelioma
por: Sage, Adam P., et al.
Publicado: (2018)

Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma
por: Kalra, Neetu, et al.
Publicado: (2015)

Modern Malignant Mesothelioma Manifestation
por: Razzak, Abrahim N, et al.
Publicado: (2023)

A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
por: Nowak, A K, et al.
Publicado: (2002)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Angiogenesis is an independent prognostic factor in malignant mesothelioma
por: Edwards, J G, et al.
Publicado: (2001)

YAP1 is essential for malignant mesothelioma tumor maintenance
por: Calvet, Loreley, et al.
Publicado: (2022)

Defining and targeting tumor-associated macrophages in malignant mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Mesothelium and Malignant Mesothelioma
por: Hiriart, Emilye, et al.
Publicado: (2019)

Malignant paratesticular mesothelioma
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Malignant mesothelioma of the tunica vaginalis
por: Abdelrahman, M, et al.
Publicado: (2012)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Cerebral metastases of malignant mesothelioma
por: Bathini, Abhijith, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pti2d5bvm9k3gve6tc403dqq2b